Christopher P. Phillips
12Patents
8h-index
25Co-inventors
72Inventor score
Filing activity: Dec 9, 1992 → Apr 1, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5302401A | Method to reduce particle size growth during lyophilization | Human Necessities | 178 | Expired |
| US5529915A | Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin | Emerging Cross-Sectional Technologies | 124 | Expired |
| US5298410A | Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life | Emerging Cross-Sectional Technologies | 69 | Expired |
| US8349321B2 | Immunoglobulin formulation and method of preparation thereof | Chemistry; Metallurgy | 54 | Active |
| US7867094B1 | Methods for promoting the development and sharing of content and a dynamically modified computer game | Human Necessities | 21 | Active |
| US8815236B2 | Method for treating multiple sclerosis and crohn's disease | Chemistry; Metallurgy | 13 | Active |
| US5389381A | Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5334382A | Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8900577B2 | Immunoglobulin formulation and method of preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US12290506B2 | Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | Human Necessities | 0 | Active |
| US11790254B2 | Method and system for detecting model file content | Physics | 0 | Active |
| US10954303B2 | Immunoglobulin formulation and method of preparation thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.